Welcome to our dedicated page for Inverse VIX S/T Futs ETNs due Mar22,2045 SEC filings (Ticker: VYLD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) brings together U.S. regulatory documents in which this security is formally identified. In multiple Form 8-K current reports filed by JPMorgan Chase & Co., VYLD appears in the table of securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934.
In those filings, the Title of each class is given as the Guarantee of Inverse VIX Short-Term Futures ETNs due March 22, 2045 of JPMorgan Chase Financial Company LLC, the Trading Symbol is listed as VYLD, and the Name of each exchange on which registered is NYSE Arca, Inc. The same tables also list JPMorgan Chase & Co. common stock, depositary shares representing interests in various preferred stock series, and other guaranteed notes and ETNs.
Through this page, users can access the underlying Form 8-K reports and related exhibits where VYLD is mentioned. These filings may cover topics such as earnings releases, changes to by-laws, or the closing of public offerings of other notes and subordinated debt, with VYLD included in the standardized disclosure of registered securities.
Stock Titan enhances these filings with AI-powered summaries that explain the main points of each document in plain language, while still preserving access to the full official text from EDGAR. Users can quickly see where VYLD appears in the filing, understand the context of the report, and navigate to other securities listed in the same disclosure table.
For deeper analysis, investors can review successive filings over time to confirm that VYLD remains listed as a registered security and to see how it is grouped with other instruments issued or guaranteed by JPMorgan Chase & Co. and JPMorgan Chase Financial Company LLC.
JPMorgan Chase & Co. filed its 2025 annual report, outlining the scale of its global banking and financial services operations and the main risks it faces. The firm reported $4.4 trillion in assets and $362.4 billion in stockholders’ equity as of December 31, 2025, underscoring its position as one of the largest U.S.-based financial institutions.
The company operates through three main segments—Consumer & Community Banking, Commercial & Investment Bank, and Asset & Wealth Management—with Corporate holding remaining activities, and is heavily supervised by U.S. and international regulators under Basel III, stress testing (CCAR and SCB), and a broad array of prudential, consumer, securities, derivatives, and anti–money laundering rules.
The report highlights extensive legal, regulatory, market, credit, liquidity, operational, conduct, strategic, reputation, country, and people risks that could materially affect earnings and capital. Human capital is a major focus: JPMorgan Chase employs 318,512 people in 66 countries, with 58% in the U.S., and discloses detailed diversity metrics by race/ethnicity, gender, LGBTQ+, veteran, and disability status.
JPMorgan Chase & Co. filed a Form 13F holdings report as an institutional investment manager. The filing shows a Form 13F Information Table with 31,795 reportable positions and a total reported value of $1,592,803,635,626. The report is filed as a full 13F holdings report, not a notice or combination report.
The filing also lists 17 other included affiliated managers, such as J.P. Morgan Trust Co of Delaware, JPMorgan Chase Bank, N.A., and several J.P. Morgan asset management entities across the U.S., Europe, and Asia.
JPMorgan Chase & Co. closed a public offering of
The company filed a legal opinion from Simpson Thacher & Bartlett LLP as Exhibit 5.1, along with the related consent and Inline XBRL cover page data as additional exhibits.
JPMorgan Chase executive Robin Leopold, Head of Human Resources, reported exempt internal transfers of company stock involving family trusts. On February 3, 2026, Form 4 shows two transactions coded "G" for 132 shares of JPMorgan Chase common stock at $0.0000 per share, reflecting non-sale trust movements.
After these transfers, Leopold beneficially owned 65,785 shares directly and 9,201 shares indirectly through grantor retained annuity trusts, including a spouse’s GRAT. The filing notes these transfers are exempt from Section 16 under Rule 16a-13, indicating no open-market buying or selling.
JPMorgan Chase & Co. director Michele Buck reported an acquisition of common stock tied to her board compensation. On January 20, 2026, she acquired 913.5251 shares of common stock at $306.505 per share through a deferral of her annual stock grant, which will be paid in shares upon termination of her service as a director. Following this transaction, she beneficially owns 918.5251 shares of JPMorgan common stock in direct ownership.
JPMorgan Chase & Co. approved 2025 annual compensation of $43.0 million for CEO James Dimon, up from $39.0 million a year earlier. His pay includes a $1.5 million base salary and $41.5 million in performance-based variable incentive compensation, with $5.0 million in cash and $36.5 million in at-risk Performance Share Units tied entirely to financial performance.
The Board cited strong firm performance, including $185.6 billion of 2025 revenue, net income of $57.0 billion or $20.02 per share, and 20% return on tangible common equity. The quarterly common dividend was raised from $1.25 to $1.50 per share. The firm ended 2025 with a 14.5% common equity Tier 1 ratio, $288 billion of CET1 capital, and $1.5 trillion of cash and marketable securities, and it raised about $3.3 trillion of credit and capital for clients.
JPMorgan Chase director Mark A. Weinberger reported the deferral of his annual stock grant into JPM common stock. On January 20, 2026, he acquired 913.5251 shares at a reference price of $306.505 per share under a deferred compensation arrangement. Following this transaction, he beneficially owns 4,111.4062 shares of JPM common stock in direct form.
According to the filing, this grant is a deferred annual stock award that will be paid in JPM shares upon his termination of service as a director, rather than being received immediately in cash or stock.
JPMorgan Chase director Phebe N. Novakovic reported receiving 913.5251 shares of common stock on January 20, 2026, as an acquisition coded "A". The filing explains this was a deferral of her annual stock grant, which will be paid in JPMorgan Chase shares when her service as a director ends. After this transaction, she beneficially owned 13,258.911 shares directly. The filing also notes an additional 45 shares of common stock held indirectly through her spouse.
Virginia M. Rometty, a director of JPMorgan Chase & Co., reported acquiring 913.5251 shares of JPM common stock on 01/20/2026 at $306.505 per share.
The transaction reflects a deferral of her annual stock grant, which is payable in JPM shares when her service as a director ends. Following this grant, she beneficially owns 14,700.1621 shares of JPM common stock in direct form.
JPMorgan Chase director Brad D. Smith reported a deferred stock award under the company’s director compensation program. On 01/20/2026, he was credited with 913.5251 shares of common stock at a price of $306.505 per share, described as a deferral of his annual stock grant payable in shares upon termination of his service as a director. Following this transaction, he directly beneficially owned 2,946.5824 shares. The filing also lists additional indirect holdings in JPMorgan Chase common stock through family trusts, his spouse, a spouse’s GRAT, and a spouse’s IRA.